C
Celltrion
Incheon, South Korea
Founded 2002 KRX: 068270
Nanomedicine Drug Delivery Protein Nanoparticles Cell Therapy Nano Nanobiomarkers Cancer Nanotherapy
About
Biosimilars and antibody drug conjugates
Company Details
- Type
- public
- Employees
- 3000+
- Funding
- Public
Key Products
- Remsima
- Herzuma
- Truxima